Drug intelligence / Profile preview

metronidazole + levothyroxine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Topical, Rectal
01

Overview

Metronidazole + levothyroxine is a combination of two pharmaceutical agents, each with distinct mechanisms and indications. Metronidazole is a nitroimidazole antibiotic and antiprotozoal agent that works by disrupting DNA synthesis in susceptible organisms, leading to cell death. It is primarily used to treat anaerobic bacterial infections and certain protozoal infections. Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4), used as hormone replacement therapy in hypothyroidism; it acts by supplementing deficient endogenous thyroid hormone, thereby normalizing metabolic activity regulated by thyroid hormones. There are no known direct pharmacokinetic or pharmacodynamic interactions between these two drugs according to major drug interaction databases[1][2]. However, anecdotal reports suggest some patients may experience altered absorption or efficacy of levothyroxine when taken concomitantly with metronidazole, though this has not been substantiated in controlled studies[3][4].

02

Targets

NeuraminidaseTHRB (Thyroid hormone receptor beta)

Beyond the preview

Go deeper on metronidazole + levothyroxine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metronidazole + levothyroxine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call